Barclays
IMA

Barclays’s ImageneBio Inc IMA Stock Holding History

Barclays’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Buy
10,959
+162
+2% +$1.05K ﹤0.01% 4284
2025
Q4 		$74.5K Buy
10,797
+6,810
+171% +$50.5K ﹤0.01% 4660
2025
Q3 		$32.5K Sell
3,987
-1,528
-28% -$20.3K ﹤0.01% 4870
2025
Q2 		$88.7K Hold
5,515
– – ﹤0.01% 4613
2025
Q1 		$84.7K Sell
5,515
-10,761
-66% -$186K ﹤0.01% 4464
2024
Q4 		$320K Hold
16,276
– – ﹤0.01% 4083
2024
Q3 		$338K Sell
16,276
-61
-0.4% -$1.23K ﹤0.01% 4015
2024
Q2 		$323K Sell
16,337
-65
-0.4% -$1.15K ﹤0.01% 3303
2024
Q1 		$279K Sell
16,402
-3,986
-20% -$72.6K ﹤0.01% 3929
2023
Q4 		$482K Buy
20,388
+3,176
+18% +$104K ﹤0.01% 3899
2023
Q3 		$894K Buy
17,212
+362
+2% +$21.8K ﹤0.01% 2410
2023
Q2 		$1.33M Buy
16,850
+347
+2% +$24.9K ﹤0.01% 2134
2023
Q1 		$683K Sell
16,503
-114
-0.7% -$5.24K ﹤0.01% 3032
2022
Q4 		$530K Sell
16,617
-152
-0.9% -$4.86K ﹤0.01% 3276
2022
Q3 		$714K Buy
16,769
+11
+0.1% +$636 ﹤0.01% 2464
2022
Q2 		$891K Sell
16,758
-375
-2% -$20.7K ﹤0.01% 2455
2022
Q1 		$1.25M Buy
+17,133
New +$1.82M ﹤0.01% 2222

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Barclays's IMA Position: Q1 2026 in Review

Barclays increased its ImageneBio Inc (IMA) stake by 1.5% in Q1 2026, buying an estimated $1.05K and bringing the position to 10,959 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4284.

Barclays first reported a position in IMA in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.33M in Q2 2023. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • Barclays held 10,959 shares of ImageneBio Inc worth $54.8K as of Q1 2026.
  • Barclays bought 162 ImageneBio Inc shares in Q1 2026, an estimated $1.05K.
  • ImageneBio Inc made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4284 holding.
  • Barclays first reported a position in ImageneBio Inc in Q1 2022 and has held it in 17 quarters since.
  • Barclays's ImageneBio Inc position peaked at $1.33M in Q2 2023.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.